Although earlier reports did not identify a correlation between CDKN2A methylation and tumor volume, invasiveness, recurrence, or malignancy, more recent studies have associated CDKN2A methylation with tumor volume, grade, and patient age [16,25,27,29,36]. This evidence concerns the gene CDKN2A and neoplasm.